Karen Dawes

Karen Dawes has held senior executive and commercial positions at key biopharmaceutical companies and was responsible for the successful launch and marketing of a number of drugs.

Karen is President and founder of Knowledgeable Decisions, LLC, a biopharma pharmaceutical consulting firm focusing on development and commercial/corporate strategy. She was Business Group Head for Bayer Corporation’s U.S. Pharmaceuticals Group, Senior Vice President, Global Strategic Marketing for Wyeth, and Chief Commercial Officer for Genetics Institute. Karen began her pharmaceutical career at Pfizer, Inc. where she held numerous positions including Vice President, Marketing for the Pratt Division. She is Chairperson of the Board of Directors of Repligen Corporation and serves as a Board Director for Medicenna Therapeutics, PaxMedica Therapeutics, and Medicines 360. She received her M.B.A. from Harvard University and her B.A. and M.A. in English from Simmons College.